Dupuytren’s contracture has no single cause. It develops from a collision of genetic susceptibility, metabolic conditions, lifestyle exposures, and possibly immune triggers that together push the connective tissue in the palm toward runaway scarring. The strongest known genetic thread runs through the Wnt signaling pathway, a set of molecular switches that control how cells grow and organize tissue. But genetics alone does not explain everything: alcohol consumption, diabetes, vibrating tool use, and even certain medications all raise the risk independently, and researchers are still working out exactly how these factors interact.
The Genetic Foundation
The clearest evidence for a genetic cause comes from genome-wide association studies comparing the DNA of thousands of people with and without the disease. A landmark study of over 2,300 patients and 11,500 controls identified variants at nine locations in the genome tied to Dupuytren’s, six of which sit in or near genes belonging to the Wnt signaling pathway. Some of these variants nearly doubled a person’s odds of developing the condition. For example, a variant in the gene SFRP4 carried an odds ratio close to 2.0, meaning carriers were roughly twice as likely to develop the disease as non-carriers.1PubMed. Wnt signaling and Dupuytren’s disease A later, larger study confirmed all of these loci and expanded the list to 27 genetic variants, reinforcing that the Wnt pathway sits at the center of the disease’s genetic architecture.2The American Journal of Human Genetics. Genome-wide association study identifies 27 variants associated with Dupuytren’s disease
What does the Wnt pathway actually do? In healthy tissue, it helps regulate how cells multiply, how they arrange themselves, and when they stop growing. When specific Wnt genes carry risk variants, the signaling goes off-kilter in the palmar fascia, the sheet of connective tissue beneath the skin of the palm. That imbalance nudges the resident cells toward excessive tissue production. One variant in the gene WNT7B, for instance, was found to increase the chances of developing Dupuytren’s contracture by about 3.5-fold in people who carry two copies of the risk version.3PubMed Central. Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren’s Contracture
There is also an epigenetic layer. A study of small RNA molecules called microRNAs in Dupuytren’s tissue found a distinctive profile of microRNAs that regulate genes in the same Wnt/beta-catenin pathway, including genes for key growth signals. These microRNAs effectively fine-tune how strongly certain genes are expressed, suggesting the disease involves not just which gene variants you carry but how actively those genes are dialed up or down in the affected tissue.4PubMed. Unique microRNA profile in Dupuytren’s contracture supports deregulation of β-catenin pathway
What Happens Inside the Palm
Genetics sets the stage, but the disease itself plays out at the cellular level through a feedback loop involving fibroblasts, the workhorse cells of connective tissue. In Dupuytren’s, fibroblasts in the palmar fascia become abnormally active and transform into a more aggressive cell type called a myofibroblast. Myofibroblasts are equipped with a contractile apparatus, meaning they can physically pull on surrounding tissue the way a muscle fiber does. In wound healing, this is useful; in Dupuytren’s, it becomes destructive.
These activated cells churn out excessive collagen and other structural proteins while also releasing growth factors that recruit and activate still more fibroblasts, creating a self-reinforcing cycle. Among the signaling molecules implicated are TGF-beta, TNF-alpha, platelet-derived growth factor, and free radicals.5PubMed Central. Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren’s disease The result is the nodules and cords that patients feel beneath the skin, which gradually shorten and pull the fingers toward the palm.
Mechanical stress feeds this loop as well. TGF-beta and physical tension work together to push precursor cells into becoming myofibroblasts, and as the cords tighten, they generate more tension, which in turn stimulates more myofibroblast activity.6PubMed Central. Mechanoregulation of the Myofibroblast in Wound Contraction, Scarring, and Fibrosis: Opportunities for New Therapeutic Intervention This is one reason the disease tends to progress rather than plateau: the tissue’s own contraction sustains the conditions that promote further contraction.
The Free Radical Theory
One of the more interesting proposed mechanisms links the disease to oxygen free radicals generated by blood-supply problems in the palm. In Dupuytren’s tissue, the tiny blood vessels are often narrowed, and fibroblasts cluster densely around them. Researchers measured the concentration of hypoxanthine, a chemical building block that reacts with an enzyme called xanthine oxidase to release damaging free radicals. In Dupuytren’s tissue, hypoxanthine levels were about six times higher than in normal palmar fascia, with the highest concentrations in the nodular areas where disease activity is greatest.7PubMed Central. Free radicals and Dupuytren’s contracture
The proposed sequence goes like this: narrowed blood vessels create pockets of poor blood flow. During these episodes of low oxygen, the body’s energy molecule breaks down into hypoxanthine. When blood flow returns, xanthine oxidase converts that hypoxanthine into free radicals. At low concentrations, free radicals can actually stimulate fibroblast growth. The result is a cycle where poor circulation drives fibroblast proliferation, which thickens the tissue further, which compresses more blood vessels.8Hand Clinics. The Role of the Fibroblast in Dupuytren’s Contracture This theory also helps explain why alcohol is a risk factor: alcohol promotes the conversion of the enzyme xanthine dehydrogenase into xanthine oxidase, amplifying free radical output.9PubMed Central. An insight into Dupuytren’s contracture
Alcohol, Tobacco, and Manual Labor
Among modifiable risk factors, alcohol consumption has the strongest evidence. A Mendelian randomization study, which uses genetic variants as stand-ins for exposure to minimize confounding, found that each additional drink per week was associated with roughly a threefold increase in odds of developing the disease.10PubMed Central. Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study That same study found no causal link between smoking and Dupuytren’s. A separate prospective study, however, reported that both alcohol and tobacco independently showed a dose-response relationship with the disease after adjusting for other factors, though the combination of heavy drinking and heavy smoking did not multiply the risk beyond what each contributed on its own.11PubMed. A prospective study linked both alcohol and tobacco to Dupuytren’s disease
A systematic review of nongenetic factors confirmed the dose-response pattern for alcohol, smoking, and manual work exposure.12Plastic & Reconstructive Surgery. Nongenetic Factors Associated with Dupuytren’s Disease: A Systematic Review The smoking question remains somewhat unsettled: the genetic-instrument study pointed away from causation, while the observational data pointed toward it. One plausible resolution is that smoking’s apparent association in some cohorts is partly driven by confounding with alcohol use or manual occupation, though the evidence is not definitive either way.
Occupational vibration exposure carries its own risk. A meta-analysis of studies on workplace mechanical exposures found that hand-transmitted vibration doubled the odds of Dupuytren’s, while heavy lifting and carrying loads raised the odds by about 50 percent.13Occupational and Environmental Medicine. Dupuytren’s disease and occupational mechanical exposures: a systematic review and meta-analysis In a surveillance study of workers, those who used vibrating tools had about five times the odds of having the disease compared to unexposed workers, and the association strengthened with longer job tenure: workers exposed for more than ten years had over ten times the odds.14PubMed Central. Heavy manual work, exposure to vibration and Dupuytren’s disease? Results of a surveillance program for musculoskeletal disorders A large population-based study of nearly 5,000 men confirmed the link, with the highest risk among those whose recent vibration exposure exceeded a specific intensity threshold.15PubMed Central. Dupuytren’s contracture and occupational exposure to hand-transmitted vibration The mechanism likely ties into the same mechanical-stress and microvascular-injury pathways described above.
The Diabetes Connection
Diabetes is one of the most consistent medical conditions linked to Dupuytren’s, and the connection appears to run through a specific chemical pathway. When blood sugar stays elevated over time, glucose reacts with proteins to form compounds called advanced glycation end products, or AGEs. In tissue samples from Dupuytren’s patients, AGE levels in the palmar fascia are significantly higher than in controls, and so are levels of the receptor that binds them.16PubMed Central. Association of advanced glycation end products in Dupuytren disease
AGEs promote fibrosis in two ways. They stiffen the tissue directly by cross-linking collagen fibers, and they trigger inflammation and oxidative stress through their receptor, pushing fibroblasts toward the myofibroblast state that drives disease progression.17PubMed Central. Associations of Glycemic Control and Diabetes Duration With Dupuytren Disease in Men and Women With Type 1 and 2 Diabetes AGE accumulation increases with both how high blood sugar runs and how long a person has had diabetes, regardless of how well their sugar is currently controlled. This means that even a person with well-managed diabetes today may carry a higher risk if they spent years with elevated glucose earlier.18Communications Medicine. The prevalence of Dupuytren’s disease in patients with diabetes mellitus
Why Men Are Affected More Often and Earlier
Dupuytren’s is far more common in men and tends to show up ten to twenty years earlier in men than in women.19Chinese Journal of Plastic and Reconstructive Surgery. Dupuytren’s disease: A review This gap is not just a matter of occupational exposure or alcohol use. Research on the tissue itself found that myofibroblasts in Dupuytren’s cords express androgen receptors at much higher levels than normal palmar fascia cells. The normal palmar fascia showed very little androgen receptor staining, while Dupuytren’s tissue lit up in many of the myofibroblasts.20PubMed. Androgen receptors in Dupuytren’s contracture This finding suggests the palmar fascia is a target tissue for androgens, and the higher circulating testosterone levels in men could drive earlier onset and faster progression. It also aligns with the clinical observation that women who develop the disease tend to do so after menopause, when hormonal profiles shift.
The “Viking Disease” Myth
Dupuytren’s contracture is sometimes called “Viking disease” because of its high prevalence in Northern European populations and the assumption that Norse seafarers spread the genetic predisposition. It makes for a good story, but the genetic evidence does not support it. A study that directly tested whether Dupuytren’s patients had excess Norse ancestry found no evidence for it.21PubMed. Is Dupuytren’s disease really a ‘disease of the Vikings’?
The geographic pattern is real, though. Prevalence does track with Northern European heritage, and a study using the 26 known genetic risk variants found that the combined genetic risk score across different populations correlated with observed disease rates, explaining about 36 percent of the variation in prevalence between ethnic groups.22European Journal of Human Genetics. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants In other words, the reason Northern Europeans get Dupuytren’s more often is not because of a single Viking migration event but because the risk variants happen to be more common in those populations, likely through ordinary genetic drift over many centuries.
Medications and the Immune System
A less well-known cause involves anti-seizure medications, particularly phenobarbital. A study of chronic epilepsy patients in a residential center found a 56 percent incidence of Dupuytren’s, with the rate climbing alongside the duration of anticonvulsant therapy. The researchers attributed this to phenobarbital’s stimulation of tissue growth factors rather than any liver or hormone pathway.23PubMed Central. Dupuytren’s disease in epilepsy: result of prolonged administration of anticonvulsants A later case series reported clinical regression of Dupuytren’s when phenobarbital was switched to carbamazepine at the same dose, reinforcing the idea that the effect is specific to phenobarbital rather than a general property of anti-seizure drugs.24PubMed. Dupuytren’s contracture as result of prolonged administration of phenobarbital
The immune system plays a larger role in Dupuytren’s than many people realize. Tissue from Dupuytren’s nodules contains dense clusters of immune cells packed around the small blood vessels, including T-cells, macrophages, and natural killer cells. The immune profile skews toward a pro-inflammatory pattern.25PubMed. Characterisation of the inflammatory response in Dupuytren’s disease Among the inflammatory signals, TNF-alpha stands out. Researchers found high levels of it in Dupuytren’s tissue, along with large numbers of classically activated macrophages.26PubMed Central. Unraveling the signaling pathways promoting fibrosis in Dupuytren’s disease reveals TNF as a therapeutic target This has opened a promising treatment angle: early trials of TNF inhibitors injected locally into nodules produced softening and size reduction, raising the possibility of controlling disease progression before it requires surgery.27PubMed. Dupuytren’s disease: a localised and accessible human fibrotic disorder
Unusual Lipid Patterns
A surprising thread in recent research connects Dupuytren’s to blood lipid profiles, though not in the direction you might expect. In a Swedish cohort of roughly 30,000 people followed for over 20 years, higher levels of ApoA1, a protein associated with “good” HDL cholesterol, predicted a higher risk of developing Dupuytren’s in both men and women. Meanwhile, a higher ratio of ApoB to ApoA1 was protective.28Scientific Reports. Metabolic factors and the risk of Dupuytren’s disease: data from 30,000 individuals followed for over 20 years A large Dutch cohort study similarly found that higher serum HDL levels were associated with the presence of Dupuytren’s.29Journal of Hand Surgery Global Online. Associations of Demographic, Lifestyle, and Clinical Factors With the Presence of Dupuytren Disease: Results from the Lifelines Cohort Study
This is counterintuitive because HDL is normally framed as heart-healthy. One speculative explanation is that certain HDL subtypes carry lipid-derived signaling molecules that promote fibroblast activity, but this remains poorly understood. The finding also does not mean that high HDL causes Dupuytren’s directly; it may reflect a shared genetic or metabolic background. Still, it reinforces the broader theme that Dupuytren’s is a systemic condition with metabolic roots, not purely a localized hand problem.
Overlap with Other Fibrotic Conditions
Dupuytren’s tends to travel with related fibrotic disorders. Patients often develop thickened nodules on the soles of the feet (Ledderhose disease), knuckle pads on the backs of the finger joints, or fibrous plaques in the penis (Peyronie’s disease).30PubMed Central. Dupuytren’s disease When a person has Dupuytren’s alongside one or more of these associated conditions, especially with early onset and a strong family history, clinicians call it “Dupuytren’s diathesis,” indicating a more aggressive, constitutionally driven form.
The overlap extends to frozen shoulder as well. A genetic comparison between Dupuytren’s and adhesive capsulitis found 13 shared genetic loci, with the shared genes concentrated in fibrotic pathways involving collagen and the extracellular matrix.31PubMed. A shared genetic architecture between adhesive capsulitis and Dupuytren disease A bioinformatics analysis confirmed that the two conditions share overlapping molecular processes involving extracellular matrix organization, collagen production, and certain cell-signaling cascades.32PubMed Central. Exploring the potential relationship between frozen shoulder and Dupuytren’s disease through bioinformatics analysis and machine learning For patients, the practical implication is that Dupuytren’s may signal a broader tendency toward fibrotic tissue reactions, which can be worth mentioning to a doctor if you develop stiffness in other joints.
Emerging Blood-Based Biomarkers
One frustrating aspect of Dupuytren’s is that by the time you notice a nodule or a finger that will not straighten, the fibrotic process is already well established. Researchers are now looking for blood-based markers that could identify the disease earlier or predict how fast it will progress. A recent study developed proteomic risk scores based on patterns of proteins circulating in the blood and achieved roughly 77 percent accuracy in distinguishing people with Dupuytren’s from controls. The same scoring tool could also differentiate patients whose disease progressed quickly from those with a slower course.33PubMed Central. Identification of novel plasma proteomic biomarkers of Dupuytren disease
A separate study investigated autoantibodies against angiotensin receptors, proteins involved in blood vessel regulation and fibrosis. In women with Dupuytren’s, levels of one specific autoantibody were significantly lower than in healthy women, and lower values correlated with more severe disease. No such pattern appeared in men.34PubMed Central. Angiotensin Receptor Autoantibodies in Dupuytren Disease: A Biomarker Study Neither biomarker is ready for routine clinical use, but they point toward a future where Dupuytren’s could be flagged and monitored through a blood test rather than waiting for visible hand deformity.